Vaccines as a Market Sector

[Moderator_02]

Quote

Vaccines: Panamanian Market Boosts Purchases

From January to September 2019, companies in the region bought vaccines for human use abroad for $154 million, 56% more than what was reported for the same period in 2018, a rise that is mainly explained by the behavior of imports in Panama.

Monday, March 9, 2020

Figures from the Trade Intelligence Unit at CentralAmericaData:

Panamanian Companies, Main Buyers
From January to September 2019, the main importer of human vaccines in Central America was Panama, with $61 million, followed by Guatemala with $31 million, Honduras with $22 million, Costa Rica with $20 million, El Salvador with $14 million and Nicaragua with $7 million.

Four of the six countries recorded year-on-year increases in purchases. In Panama imports increased 292%, while in Honduras, Costa Rica and El Salvador the increases were 32%, 24% and 19%, in that order.

Guatemala and Nicaragua were the markets that registered negative variations, reporting decreases of 2% and 3%, respectively.

Variation of Regional Business
Between January and September 2018 and the same period in 2019, the value imported into the region grew considerably, from $99 million to $154 million.

For the periods in question, purchases from U.S. companies increased from $18 million to $41 million.

U.S., Main Supplier 
As of September, this year, 27% of the value imported into the region came from the United States, 20% from Belgium, 17% from France, 9% from South Korea and 9% from India.

 

https://www.centralamericadata.com/en/article/main/Vaccines_Panamanian_Market_Boosts_Purchases